PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain.\', \'Jimenez Diaz Foundation University Hospital, FJD Health Research Institute, IIS-FJD UAM, Madrid, Spain. lucia.llanos@quironsalud.es.\', \'La Paz University Hospital, Madrid, Spain.\', \'Navarra University Clinic, Pamplona, Navarra, Spain.\', \'Virgen de la Arrixaca University Hospital, Murcia, Spain.\', \'IBSAL-University Hospital of Salamanca, University of Salamanca, Salamanca, Spain.\', \'Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.\', \'Queen Victoria Eugenia-Cruz Roja Hospital, Sevilla, Spain.\', \'University of Pablo de Olavide, Sevilla, Spain.\', \'Network Center for Research in Diabetes and Associated Metabolic Diseases (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas-CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.\', \'La Fe University Hospital, Valencia, Spain.\', \'Valladolid Clinical University Hospital, Valladolid, Spain.\', \'Institute for Health Research Gregorio Marañón (IISGM), General University Gregorio Marañón Hospital, Madrid, Spain.\', \'Institute for Health Research-ISABIAL, General University Hospital, Alicante, Spain.\', \'University Miguel Hernández de Elche, Alicante, Spain.\', \'The Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain.\', \'University of Alicante, Alicante, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-021-05430-2
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 34488845
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34488845>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34488845>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all